Drug Price Trends for SM ALLERGY

Average Pharmacy Cost for SM ALLERGY

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
SM ALLERGY (DIPHEN) 25 MG CAP	70677-0002-02	0.04248	EACH	2025-01-22
SM ALLERGY (DIPHEN) 25 MG TAB	70677-0003-01	0.03643	EACH	2025-01-22
SM ALLERGY RELIEF 50 MCG SPRAY	49348-0182-67	0.69992	ML	2025-01-22
SM ALLERGY 4 MG TABLET	70677-0004-01	0.01669	EACH	2025-01-22

Market Analysis and Price Projections for Allergy Therapeutics: A Comprehensive Overview

Introduction to the Allergy Therapeutics Market

The global allergy therapeutics market is experiencing significant growth, driven by increasing prevalence of allergic diseases, advancements in medical science, and rising demand for effective treatments. Here’s a detailed analysis of the market and its projections.

Market Size and Growth Projections

The global allergy therapeutics market is anticipated to grow substantially over the next decade. By 2033, the market is expected to reach USD 42.5 billion, up from USD 23.1 billion in 2023, at a compound annual growth rate (CAGR) of 6.29%[1].

Another projection suggests that the market will reach USD 34.9 billion by 2034, growing at a CAGR of 5.8%[2].

Segmentation of the Allergy Therapeutics Market

By Treatment Type

The market is segmented into anti-allergy drugs and immunotherapy. Anti-allergy drugs, which include antihistamines, corticosteroids, and decongestants, dominate the market with the largest revenue share. This segment is driven by the convenience of self-administration and the increasing development of pediatric-friendly anti-allergy drugs[1][3].

By Allergy Type

The market is also segmented by allergy type, including eye allergy, asthma, skin allergy, rhinitis, and others. The rhinitis segment holds the largest revenue share due to its high prevalence and the need for continuous treatment[1].

By Route of Administration

The route of administration includes oral, inhalers, intranasal, and others. The inhaled allergy segment is significant due to the impact of poor air quality and increasing pollution[2].

By Distribution Channel

Hospital pharmacies are the largest distribution channel, followed by retail pharmacies and others. The dominance of hospital pharmacies is due to their extensive network and patient access[2].

Regional Analysis

North America

North America leads the market with the largest share, driven by advanced healthcare systems, well-established medical facilities, and significant investments in biotechnology and immunology. The region's high prevalence of allergic conditions and increasing awareness about health impacts also contribute to its market dominance[1][5].

Asia-Pacific

The Asia-Pacific region is expected to grow the fastest during the forecast period. Factors such as increasing urbanization, healthcare developments in countries like India and China, and rising awareness about advanced treatments are driving this growth[1].

Europe

Europe is another key market, with a focus on sustainable medicines and treatments. The region's growing sustainability trends are expected to fuel the demand for eco-friendly and innovative allergy treatments[2].

Key Drivers of the Market

Increasing Prevalence of Allergic Diseases

The rising number of allergic patients due to changing lifestyles, poor air quality, and increasing pollution is a fundamental driver of the market. For instance, over 100 million Americans are affected by various types of allergies each year[5].

Advancements in Medical Science and Technology

Technological advancements in pharmaceutical manufacturing and the development of new treatment technologies, such as immunotherapy products, are driving the market. The approval of treatments like Xolair (omalizumab) for immunoglobulin E-mediated food allergy is a significant example[5].

Growing Demand for Self-Medication

The preference for over-the-counter drugs and self-medication among consumers is another key driver. This trend is fueled by the convenience and ease of use of oral dosage forms[3].

Competitive Landscape

The market is competitive, with major players such as GlaxoSmithKline, ALK-Abelló A/S, Sallergenes Greer, Allergy Therapeutics, Sanofi SA, Johnson & Johnson, and Merck Co. Inc. These companies are investing heavily in R&D and introducing innovative products to gain a competitive edge[3].

Key Developments

• ALK-Abelló A/S: Entered the Chinese market more easily due to government waivers of regulatory policies, enhancing its global position[2].
• Genentech: Received FDA approval for Xolair, an anti-allergy injection, which has been crucial for its market position[2].

Pricing and Cost Considerations

The cost of allergy treatments can be significant, with some procedures being excessively priced. For example, a case in the San Francisco Bay Area highlighted an allergy patch test costing over $12,000, which is far above the usual and customary charges[4].

Average Costs

• The average charge for testing a single allergen can range from $16 to $35, depending on the region and provider[4].

Future Trends and Opportunities

Personalized Treatments

Tailoring allergy treatments to individual needs and sensitivities is a growing trend. This approach is expected to improve patient care and treatment outcomes[5].

Telemedicine and Wearable Devices

Advancements in telemedicine, wearable devices, and allergy monitoring tools are expected to enhance patient care and treatment outcomes. These technologies will make it easier for patients to manage their allergies remotely and receive timely interventions[5].

Immunotherapy

Subcutaneous Immunotherapy (SCIT) is expected to secure a significant portion of the market due to its efficacy. The innovative launch of immunotherapy products, such as Xolair, will drive this segment's growth[5].

Key Takeaways

• The global allergy therapeutics market is projected to grow significantly, reaching USD 42.5 billion by 2033.
• Anti-allergy drugs dominate the market, with a focus on pediatric-friendly formulations.
• North America leads the market, while the Asia-Pacific region is expected to grow the fastest.
• Technological advancements and increasing prevalence of allergic diseases are key drivers.
• Personalized treatments, telemedicine, and immunotherapy are future trends.

FAQs

What is the projected size of the global allergy therapeutics market by 2033?

The global allergy therapeutics market is expected to reach USD 42.5 billion by 2033[1].

Which region dominates the allergy therapeutics market?

North America dominates the market with the largest share, driven by advanced healthcare systems and significant investments in biotechnology and immunology[1][5].

What are the main treatment types in the allergy therapeutics market?

The main treatment types are anti-allergy drugs and immunotherapy, with anti-allergy drugs holding the largest revenue share[1][3].

What are the key drivers of the allergy therapeutics market?

Key drivers include the increasing prevalence of allergic diseases, advancements in medical science and technology, and growing demand for self-medication[1][2][5].

How is the Asia-Pacific region contributing to the market growth?

The Asia-Pacific region is growing rapidly due to increasing urbanization, healthcare developments, and rising awareness about advanced treatments[1].

What are some future trends in the allergy therapeutics market?

Future trends include personalized treatments, advancements in telemedicine and wearable devices, and the growth of immunotherapy[5].

Sources

1. Global Allergy Therapeutics Market Size To Exceed USD 42.5 Billion By 2033 - GlobeNewswire
2. Allergy Treatment Market Size and Share Projected to Surpass USD 34.9 Billion by 2034 - GlobeNewswire
3. Allergy Treatment Market Size, Share | Statistics Report - 2031 - Allied Market Research
4. That's A Lot Of Scratch: The $48,329 Allergy Test - KFF Health News
5. Allergy Treatment Market Analysis | Industry Forecast, Size & Report - Mordor Intelligence